We founded Absci with the goal of creating better medicines and helping them reach patients sooner. We recognized the extraordinary medical and economic potential of protein-based drugs (biologics), but also the significant challenges the biopharmaceutical industry faces to both discover novel biologics and generate cell lines to manufacture them at commercial scale. We looked at the end game – getting better medicines to patients, faster — and asked: how? We built our technology to be that how.
Lead Underwriter
BofA Securities, Inc, Cowen and Company, LLC, Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC, Stifel Nicolaus & Company, Incorporated
